FEMARA
FEMARA
Approved
DIN Number
02231384
Drug Class
Human
Market Date
Aug 18, 1997
Company
HC
novartis pharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02231384
AIG Number0132937001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L02BG04 LETROZOLE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
LETROZOLEActive
Strength: 2.5 MG
Monograph: LETROZOLE